Pharma stock engaged in manufacturing, marketing, and distribution of medical products and medical education services to clinics, pharma, medical companies, and others jumped 4 percent in the day’s trade upon signing an MoU with CSC e-Governance Services India
Price Action
With a market capitalization of Rs. 257 Crores, the shares of QMS Medical Allied Services Limited were trading at Rs. 144.25 per equity share, down 2.3 percent from its previous day’s close price of Rs. 147.65.
What Happened
QMS Medical Allied Services Limited engaged in manufacturing and distributing medical devices has entered into a Memorandum of Understanding (MoU) with CSC e-Governance Services India Limited.
The said MOU is to assist in identifying and undertaking new opportunities at both central and state levels in the area of Health Services to be delivered through the Common Service Centre or otherwise in liaison with various state government departments/ Agencies/ Corporations/ Entities.
About the company
QMS Medical Allied Services Limited is engaged in manufacturing, marketing, and distribution of medical products and medical education services to clinics, pharma, medical companies, and also to individual users
Financials and Ratios
Its revenue from operations grew by 17.39 percent from Rs. 104 Crores in FY23 to Rs. 122 Crores in FY24, accompanied by profits of Rs. 6 Crores to Rs. 9 Crores.
In terms of Return ratios, it has reported a return on equity (ROE) of 12.1 percent, and a return on capital employed (ROCE) of 14.7 percent. It has reported a debt-to-equity ratio of 0.44.
Written by: Bharath K.S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
